Evidence map›Paper›PMID 35864308›Full record

ArticleExperimental & molecular medicine2022

ROS-activated CXCR2

Yaoxian Xiang, Junxi Dai, Yao Li, Zongqi You, Junpeng Zhang, Xinying Huang, Shuqi Nie, Yujie Chen, Lei Xu, Fengming Liu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. S100A8/S100A9 released by CD11bExperimental & molecular medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Yaoxian Xiang *Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Junxi Dai *Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Yao Li *National Facility for Protein Science in Shanghai, Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, 201210, People's Republic of China.
Zongqi You *Department of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Junpeng ZhangSchool of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
Xinying HuangDepartment of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Shuqi NieShanghai Medical College of Fudan University, Shanghai, People's Republic of China.
Yujie ChenDepartment of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Lei XuDepartment of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China.
Fengming LiuNational Facility for Protein Science in Shanghai, Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, 201210, People's Republic of China.
Junjian JiangDepartment of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. jjjdoctor@126.com.
Jianguang XuDepartment of Hand Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. jianguangxu@fudan.edu.cn.
Fudan University · CNHuashan Hospital · CNShanghai Advanced Research Institute · CNShanghai Institute of Hematology · CNShanghai Medical College of Fudan University · CNShanghai University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophils are the earliest master inflammatory regulator cells recruited to target tissues after direct infection or injury. Although inflammatory factors are present in muscle that has been indirectly disturbed by peripheral nerve injury, whether neutrophils are present and play a role in the associated inflammatory process remains unclear. Here, intravital imaging analysis using spinning-disk confocal intravital microscopy was employed to dynamically identify neutrophils in denervated muscle. Slice digital scanning and 3D-view reconstruction analyses demonstrated that neutrophils escape from vessels and migrate into denervated muscle tissue. Analyses using reactive oxygen species (ROS) inhibitors and flow cytometry demonstrated that enhanced ROS activate neutrophils after denervation. Transcriptome analysis revealed that the vast majority of neutrophils in denervated muscle were of the CXCR2 subtype and were recruited by CXCL1. Most of these cells gradually disappeared within 1 week via P53-mediated apoptosis. Experiments using specific blockers confirmed that neutrophils slow the process of denervated muscle atrophy. Collectively, these results indicate that activated neutrophils are recruited via chemotaxis to muscle tissue that has been indirectly damaged by denervation, where they function in delaying atrophy.

Indexed as

Muscle DenervationTumor Suppressor Protein p53ApoptosisChemokine CXCL1HumansMuscle, SkeletalMuscular AtrophyNeutrophil ActivationNeutrophilsReactive Oxygen SpeciesChemokine CXCL1CXCL1 protein, humanReactive Oxygen SpeciesTumor Suppressor Protein p53

Identifiers

PMID35864308
PMCPMC9356135
OpenAlexW4286111174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.